Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Operating Leases of $4.3 million for Q1 2026, down 12.06% sequentially from $4.9 million in Q4 2025, and down 16.47% YoY from $5.2 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $4.3 million in Q1 2026.
- Quarterly Operating Leases fell 16.47% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 16.47% YoY) and the FY2025 annual result came in at $4.9 million, changed 0.0% from the prior year.
- Operating Leases retreated to $4.3 million in Q1 2026 per CPIX's latest filing, from $4.9 million in the prior quarter.
- Over five years, Operating Leases peaked at $5.8 million in Q2 2023 and troughed at $22712.0 in Q1 2022.
- A 5-year average of $4.2 million and a median of $4.9 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases sank 97.12% in 2022, then soared 20627.01% in 2023.
- Over 5 years, Operating Leases stood at $4.8 million in 2022, then climbed by 18.6% to $5.6 million in 2023, then decreased by 12.48% to $4.9 million in 2024, then changed by 0.0% to $4.9 million in 2025, then decreased by 12.06% to $4.3 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $4.3 million, $4.9 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Cumberland Pharmaceuticals | 117.08 Mn | 113.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.71 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 4.94 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 5.80 Mn |
| Mar 31, 2023 | 4.71 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 229,605.00 |
| Jun 30, 2022 | 512,324.00 |
| Mar 31, 2022 | 22,712.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 229,605.00 |